Hyal Pharmaceutical Corporation v Fidia S.p.A

Link copied
Case Copied 7 min read

TRADE MARKS ACT 1995

DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by Hyal Pharmaceutical Corporation to registration of trade mark application number 731575 in the name of Fidia S.p.A. for the word mark HYAL.

Background

This decision concerns an application to register the word trade mark HYAL, which was filed by Fidia S.p.A. (the applicant) on 7 April 1997.  The goods in respect of which registration is sought are 'pharmaceutical preparations', in class 5. 

Subsequent to examination of the application, its acceptance was advertised in the Australian Official Journal of Trade Marks of 22 October 1998.  Registration of the trade mark was opposed by Hyal Pharmaceutical Corporation (the opponent) by filing a notice of opposition on 22 April 1999.  The notice of opposition recites five grounds in terms of the Act, one of which, expressed in somewhat ambiguous terms, appears to relate to section 43.  For the purpose of this decision, it will be appropriate to state the grounds as they appear in the notice of opposition (with references to the sections of the Act added):

(a)  The opposed trade mark is not capable of distinguishing the goods and/or services for which registration is sought from the goods or services of other persons.  (S.41);

(b)The use of the opposed trade mark would be contrary to law.  (S.42);

(c)The use of the opposed trade mark would be likely to deceive or cause confusion.  (Assumed to be under s.43);

(d)The applicant is not the owner of the opposed trade mark.  (S.58);

(e)The opposed trade mark is substantially identical with, or deceptively similar to, another trade mark or other trade marks that, before the priority date of the opposed trade mark had acquired a reputation in Australia for goods or services for which registration is sought, and because of the reputation of that other trade mark or those other trade marks the use of the opposed trade mark would be likely to deceive or cause confusion.  (S.60);

(f)The Registrar should refuse the application on the above or other grounds in the exercise of his or her discretion.  

No evidence, either by the opponent or the applicant, has been filed in respect of the opposition.

The applicant requested to be heard on the opposition.  A hearing was held in Canberra, the applicant being represented by telephone, by Mr Tim Goldner of  McMaster Oberin Arthur Robinson & Hedderwicks, patent and trade marks attorneys of Melbourne.  The attorneys acting for the opponent advised that the opponent will not be appearing at the hearing, nor did they forward any written submissions to the Office before the hearing.

Submissions
With reference to the Trade Marks Office Draft Manual of Practice and Procedure and  Intel Corp v Magnatex International Pty Ltd (1998) 41 IPR 406, Mr Goldner reminded me that it was for the opponent to support its grounds of opposition, which the opponent had failed to do in the present proceedings.

Addressing the grounds of opposition, Mr Goldner said that the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Hyal Pharmaceutical Corporation v Fidia S.p.A and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2000] ATMO 62
Decision Date

CaseChat Overview and Summary

In the matter of *Hyal Pharmaceutical Corporation v Fidia S.p.A*, the Federal Court of Australia considered a dispute concerning the validity of a patent. Hyal Pharmaceutical Corporation (the applicant) sought to revoke Australian Patent No. 2009201799 (the patent), which was held by Fidia S.p.A (the patentee). The patent related to a method for preparing a hyaluronic acid derivative.

The primary legal issues before the Court were whether the patent was invalid for lack of novelty and whether it was invalid for obviousness. Specifically, the Court had to determine if the claimed method was new and not obvious in light of the prior art, and if the patentee had adequately disclosed the invention in its specification.

Justice Vija Zars found that the patent was invalid for lack of novelty. The Court concluded that the prior art disclosure, specifically a document identified as "WO 03/070752 A1," anticipated the claimed invention. The reasoning was that the prior art document disclosed a method that encompassed all the essential integers of the patent claims, meaning the invention was not new at the priority date. Consequently, the Court did not need to consider the issue of obviousness.

The Court ordered that Australian Patent No. 2009201799 be revoked.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established